de Melo Gagliato, Debora <br/><br/>
Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unit.  [electronic resource] 

 -  Clinical breast cancer  Dec 2014 
 - 468-74 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1938-0666 
<br/><br/><label>Standard No.: </label>10.1016/j.clbc.2014.06.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biomarkers, Tumor--genetics<br/>Breast Neoplasms--genetics<br/>Carcinoma, Ductal, Breast--genetics<br/>Carcinoma, Lobular--genetics<br/>Female<br/>Follow-Up Studies<br/>Gene Amplification<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Middle Aged<br/>Mutation--genetics<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Prognosis<br/>Proto-Oncogene Proteins c-met--genetics<br/>Survival Rate